Trial Profile
Meloxicam (MOBIC) Ampoule Post Marketing Surveillance Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 May 2019
Price :
$35
*
At a glance
- Drugs Meloxicam (Primary)
- Indications Ankylosing spondylitis; Osteoarthritis; Pain; Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim
- 15 Jul 2014 New trial record
- 08 Jul 2014 Results published in the Boehringer Ingelheim website.